Return
Broad-spectrum anti-influenza activity of the NMPA-approved drug Pamiparib is uncovered by virtual docking to the evolutionarily conserved domain of IAV-M2 protein
M
D
W
Z
L
P
L
DOI:10.1016/j.bmc.2025.118518.png)
Abstract
En 中文
• This study designs drugs targeting evolutionarily conserved regions of viral proteins, which can overcome the disadvantage that drugs screened by traditional methods are susceptible to viral protein mutations. • Drugs designed by targeting evolutionarily conserved domains of viral proteins shared by different strains and subgroups have broad-spectrum antiviral effects. • It provides a feasible method for screening broad-spectrum antiviral drugs.
Journal
B
IF:
3
Papers:
1.7W
Citations:
2.7W
